Helicobacter pylori infection Influence the Adverse Cardiovascular Events

Helicobacter pylori infection Influence the Adverse Cardiovascular Events - HP infection Influence the Adverse Cardiovascular Events

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035696

Enrollment

Registered

2019-01-28

Start date

2019-01-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with coronary heart diseaase requring percutaneous coronary intervention

Exclusion criteria

Exclusion criteria: 1) past history of eradication for Helicobacter pylori 2)end stage renal failure on hemodialysis 3)hemodynamically unstable condition

Design outcomes

Primary

Measure	Time frame
Adverse Cardiovascular Events	—

Secondary

Measure	Time frame
inflammatory markers	—

Countries

Japan

Contacts

Public ContactDaisuke Sueta

Kumamoto University Hospital Department of Cardiovascular Medicine

sueta-d@kumamoto-u.ac.jp096-373-5175

Outcome results